EDTA Eye Drops Compared to Abreva for Herpes Simplex Virus Eruptions
Condition:   Herpes Simplex Oral Interventions:   Drug: EDTA;   Drug: Abreva Sponsor:   University of Utah Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 19, 2021 Category: Research Source Type: clinical trials

A Study on the Reactogenicity, Safety and Immune Response of a Vaccine Against Herpes Simplex Virus (HSV)-2 in Healthy Participants Aged 18-40 Years
Condition:   Herpes Simplex Interventions:   Biological: Lower dose formulation of HSV vaccine (GSK4108771A);   Biological: Low dose formulation of HSV vaccine (GSK4108771A);   Biological: Medium dose formulation of HSV vaccine (GSK4108771A);   Biological: High dose formulation of HSV vaccine (GSK4108771A);   Drug: Placebo (saline) Sponsor:   GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2021 Category: Research Source Type: clinical trials